KM1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KM1, covering 2024-08-13 to 2024-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer [Phase 1]